instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'AMLODIPINE BESYLATE'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33604051 | 19,837,038 | 2021-03 |
What was the administration route of drug 'BROTIZOLAM'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33604051 | 19,837,038 | 2021-03 |
What was the administration route of drug 'DENOSUMAB'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 33604051 | 19,790,942 | 2021-03 |
What was the administration route of drug 'DOXAZOSIN MESYLATE'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33604051 | 19,837,038 | 2021-03 |
What was the administration route of drug 'GLIMEPIRIDE'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33604051 | 19,837,038 | 2021-03 |
What was the administration route of drug 'INDOMETHACIN'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Topical | DrugAdministrationRoute | CC BY-NC-ND | 33604051 | 19,837,038 | 2021-03 |
What was the administration route of drug 'LETROZOLE'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33604051 | 19,790,942 | 2021-03 |
What was the administration route of drug 'LOPERAMIDE HYDROCHLORIDE'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33604051 | 19,837,038 | 2021-03 |
What was the administration route of drug 'LOXOPROFEN SODIUM DIHYDRATE'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33604051 | 19,837,038 | 2021-03 |
What was the administration route of drug 'PRAVASTATIN SODIUM'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33604051 | 19,837,038 | 2021-03 |
What was the administration route of drug 'REBAMIPIDE'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33604051 | 19,837,038 | 2021-03 |
What was the administration route of drug 'VALSARTAN'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33604051 | 19,837,038 | 2021-03 |
What was the outcome of reaction 'Hypoglycaemia'? | Severe hypoglycaemia under abemaciclib administration in a patient with breast cancer: A case report.
The current study reports the case of an 80-year-old woman who experienced severe hypoglycaemia after abemaciclib administration, with a recovery time of ~46 h. Abemaciclib is a cyclin-dependent kinase 4 and 6 (CDK4/6)... | Recovered | ReactionOutcome | CC BY-NC-ND | 33604051 | 19,837,038 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Recurrent Leiomyosarcoma With Malignant Transformation.
The soft tissues are comprised of various structures and supportive tissues in the body, including muscle, connective tissues, endothelium, synovium, fat, lymphatics, and fascia. Soft tissue sarcomas may arise in any part of the body. The most common sites are the... | CISPLATIN, DOXORUBICIN | DrugsGivenReaction | CC BY | 33604210 | 18,962,420 | 2021-01-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Recurrent Leiomyosarcoma With Malignant Transformation.
The soft tissues are comprised of various structures and supportive tissues in the body, including muscle, connective tissues, endothelium, synovium, fat, lymphatics, and fascia. Soft tissue sarcomas may arise in any part of the body. The most common sites are the... | CISPLATIN, DOXORUBICIN | DrugsGivenReaction | CC BY | 33604210 | 18,962,420 | 2021-01-13 |
What was the administration route of drug 'CISPLATIN'? | Recurrent Leiomyosarcoma With Malignant Transformation.
The soft tissues are comprised of various structures and supportive tissues in the body, including muscle, connective tissues, endothelium, synovium, fat, lymphatics, and fascia. Soft tissue sarcomas may arise in any part of the body. The most common sites are the... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33604210 | 18,962,420 | 2021-01-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Herpes simplex virus-2 associated with a large fungating penile mass.
A 48-year-old male with HIV/AIDS presented with an enlarging nodular lesion on the base of his penis. Histology revealed changes consistent with chronic viral infection and culture grew herpes simplex virus 2 (HSV-2). The lesion was refractory to val... | CIDOFOVIR, TRIFLURIDINE, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33604244 | 18,987,611 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathogen resistance'. | Herpes simplex virus-2 associated with a large fungating penile mass.
A 48-year-old male with HIV/AIDS presented with an enlarging nodular lesion on the base of his penis. Histology revealed changes consistent with chronic viral infection and culture grew herpes simplex virus 2 (HSV-2). The lesion was refractory to val... | CIDOFOVIR, TRIFLURIDINE, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33604244 | 18,987,611 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Herpes simplex virus-2 associated with a large fungating penile mass.
A 48-year-old male with HIV/AIDS presented with an enlarging nodular lesion on the base of his penis. Histology revealed changes consistent with chronic viral infection and culture grew herpes simplex virus 2 (HSV-2). The lesion was refractory to val... | CIDOFOVIR, TRIFLURIDINE, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33604244 | 18,987,611 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Viral mutation identified'. | Herpes simplex virus-2 associated with a large fungating penile mass.
A 48-year-old male with HIV/AIDS presented with an enlarging nodular lesion on the base of his penis. Histology revealed changes consistent with chronic viral infection and culture grew herpes simplex virus 2 (HSV-2). The lesion was refractory to val... | CIDOFOVIR, TRIFLURIDINE, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC-ND | 33604244 | 18,987,611 | 2021-05 |
What was the administration route of drug 'CIDOFOVIR'? | Herpes simplex virus-2 associated with a large fungating penile mass.
A 48-year-old male with HIV/AIDS presented with an enlarging nodular lesion on the base of his penis. Histology revealed changes consistent with chronic viral infection and culture grew herpes simplex virus 2 (HSV-2). The lesion was refractory to val... | Intralesional | DrugAdministrationRoute | CC BY-NC-ND | 33604244 | 18,987,611 | 2021-05 |
What was the administration route of drug 'TRIFLURIDINE'? | Herpes simplex virus-2 associated with a large fungating penile mass.
A 48-year-old male with HIV/AIDS presented with an enlarging nodular lesion on the base of his penis. Histology revealed changes consistent with chronic viral infection and culture grew herpes simplex virus 2 (HSV-2). The lesion was refractory to val... | Topical | DrugAdministrationRoute | CC BY-NC-ND | 33604244 | 18,987,611 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaphylactic reaction'. | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | ACETAMINOPHEN, AMOXICILLIN\CLAVULANATE POTASSIUM, CHLORPHENIRAMINE MALEATE, IBUPROFEN | DrugsGivenReaction | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug hypersensitivity'. | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | ACETAMINOPHEN, AMOXICILLIN\CLAVULANATE POTASSIUM, CHLORPHENIRAMINE MALEATE, IBUPROFEN | DrugsGivenReaction | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | ACETAMINOPHEN, AMOXICILLIN\CLAVULANATE POTASSIUM, CHLORPHENIRAMINE MALEATE, IBUPROFEN | DrugsGivenReaction | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rhinorrhoea'. | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | ACETAMINOPHEN, AMOXICILLIN\CLAVULANATE POTASSIUM, CHLORPHENIRAMINE MALEATE, IBUPROFEN | DrugsGivenReaction | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Type I hypersensitivity'. | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | AMOXICILLIN | DrugsGivenReaction | CC BY-NC | 33604273 | 19,111,110 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Wheezing'. | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | ACETAMINOPHEN, AMOXICILLIN\CLAVULANATE POTASSIUM, CHLORPHENIRAMINE MALEATE, IBUPROFEN | DrugsGivenReaction | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
What was the administration route of drug 'ACETAMINOPHEN'? | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | Oral | DrugAdministrationRoute | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
What was the administration route of drug 'AMOXICILLIN\CLAVULANATE POTASSIUM'? | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | Oral | DrugAdministrationRoute | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
What was the administration route of drug 'CHLORPHENIRAMINE MALEATE'? | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | Oral | DrugAdministrationRoute | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
What was the administration route of drug 'IBUPROFEN'? | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | Oral | DrugAdministrationRoute | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
What was the dosage of drug 'ACETAMINOPHEN\HYDROCODONE'? | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | UNKNOWN | DrugDosageText | CC BY-NC | 33604273 | 19,026,862 | 2021-01 |
What was the outcome of reaction 'Anaphylactic reaction'? | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | Recovered | ReactionOutcome | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
What was the outcome of reaction 'Angioedema'? | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | Recovered | ReactionOutcome | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
What was the outcome of reaction 'Dyspnoea'? | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | Recovered | ReactionOutcome | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
What was the outcome of reaction 'Rhinorrhoea'? | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | Recovered | ReactionOutcome | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
What was the outcome of reaction 'Urticaria'? | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | Recovered | ReactionOutcome | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
What was the outcome of reaction 'Wheezing'? | Outcome of drug provocation testing in children with suspected beta-lactam hypersensitivity.
Suspicion of beta-lactam (BL) hypersensitivity is often based on parental report. Evaluation is important as incorrect labelling has clinical consequence.
To describe the outcomes of drug provocation test (DPT) in children with... | Recovered | ReactionOutcome | CC BY-NC | 33604273 | 18,987,981 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adrenocortical insufficiency acute'. | Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology.
BACKGROUND
Adrenocortical carcinoma (ACC) is an uncommon malignancy with an estimated 15,400 new cases annually across the globe. The prognosis is generally poor as the disease is often already advance... | MITOTANE | DrugsGivenReaction | CC BY | 33604708 | 20,461,114 | 2021-02-18 |
What was the outcome of reaction 'Adrenocortical insufficiency acute'? | Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology.
BACKGROUND
Adrenocortical carcinoma (ACC) is an uncommon malignancy with an estimated 15,400 new cases annually across the globe. The prognosis is generally poor as the disease is often already advance... | Recovered | ReactionOutcome | CC BY | 33604708 | 20,461,114 | 2021-02-18 |
What was the dosage of drug 'GEMCITABINE HYDROCHLORIDE'? | Right atrial cardiac angiosarcoma treated with concurrent proton beam therapy and paclitaxel: A novel approach to a rare disease.
Cardiac angiosarcoma is a rare malignancy with an aggressive course and poor prognosis. We present a 26-year old man who came to our clinic with shortness of breath and was diagnosed with a ... | 900 MG/M2, CYCLIC DAYS 1 AND 8, 3 CYCLES | DrugDosageText | CC BY | 33605065 | 19,051,894 | 2021-04 |
What was the dosage of drug 'GEMCITABINE\GEMCITABINE HYDROCHLORIDE'? | Right atrial cardiac angiosarcoma treated with concurrent proton beam therapy and paclitaxel: A novel approach to a rare disease.
Cardiac angiosarcoma is a rare malignancy with an aggressive course and poor prognosis. We present a 26-year old man who came to our clinic with shortness of breath and was diagnosed with a ... | DAYS 1 AND 8 | DrugDosageText | CC BY | 33605065 | 18,959,020 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Venous sinus thrombosis during COVID-19 infection in pregnancy: a case report.
Although it is known that the new coronavirus disease (COVID-19), which was first seen in Wuhan, China, in December 2019 and has affected the whole world, mainly targets the respiratory tract, cases of this disease with a wide clinical spect... | ACETAMINOPHEN, BETAMETHASONE, NIFEDIPINE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33605306 | 19,062,445 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Normal newborn'. | Venous sinus thrombosis during COVID-19 infection in pregnancy: a case report.
Although it is known that the new coronavirus disease (COVID-19), which was first seen in Wuhan, China, in December 2019 and has affected the whole world, mainly targets the respiratory tract, cases of this disease with a wide clinical spect... | ACETAMINOPHEN, BETAMETHASONE, CEFTRIAXONE, HYDROXYCHLOROQUINE, NIFEDIPINE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33605306 | 19,070,603 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature delivery'. | Venous sinus thrombosis during COVID-19 infection in pregnancy: a case report.
Although it is known that the new coronavirus disease (COVID-19), which was first seen in Wuhan, China, in December 2019 and has affected the whole world, mainly targets the respiratory tract, cases of this disease with a wide clinical spect... | ACETAMINOPHEN, BETAMETHASONE, CEFTRIAXONE, HYDROXYCHLOROQUINE, NIFEDIPINE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 33605306 | 19,070,603 | 2021 |
What was the administration route of drug 'ACETAMINOPHEN'? | Venous sinus thrombosis during COVID-19 infection in pregnancy: a case report.
Although it is known that the new coronavirus disease (COVID-19), which was first seen in Wuhan, China, in December 2019 and has affected the whole world, mainly targets the respiratory tract, cases of this disease with a wide clinical spect... | Transplacental | DrugAdministrationRoute | CC BY | 33605306 | 19,062,445 | 2021 |
What was the administration route of drug 'BETAMETHASONE'? | Venous sinus thrombosis during COVID-19 infection in pregnancy: a case report.
Although it is known that the new coronavirus disease (COVID-19), which was first seen in Wuhan, China, in December 2019 and has affected the whole world, mainly targets the respiratory tract, cases of this disease with a wide clinical spect... | Transplacental | DrugAdministrationRoute | CC BY | 33605306 | 19,062,445 | 2021 |
What was the administration route of drug 'NIFEDIPINE'? | Venous sinus thrombosis during COVID-19 infection in pregnancy: a case report.
Although it is known that the new coronavirus disease (COVID-19), which was first seen in Wuhan, China, in December 2019 and has affected the whole world, mainly targets the respiratory tract, cases of this disease with a wide clinical spect... | Transplacental | DrugAdministrationRoute | CC BY | 33605306 | 19,062,445 | 2021 |
What was the administration route of drug 'UNSPECIFIED INGREDIENT'? | Venous sinus thrombosis during COVID-19 infection in pregnancy: a case report.
Although it is known that the new coronavirus disease (COVID-19), which was first seen in Wuhan, China, in December 2019 and has affected the whole world, mainly targets the respiratory tract, cases of this disease with a wide clinical spect... | Transplacental | DrugAdministrationRoute | CC BY | 33605306 | 19,062,445 | 2021 |
What was the outcome of reaction 'Foetal exposure during pregnancy'? | Venous sinus thrombosis during COVID-19 infection in pregnancy: a case report.
Although it is known that the new coronavirus disease (COVID-19), which was first seen in Wuhan, China, in December 2019 and has affected the whole world, mainly targets the respiratory tract, cases of this disease with a wide clinical spect... | Recovered | ReactionOutcome | CC BY | 33605306 | 19,062,445 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cystitis haemorrhagic'. | Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.
BACKGROUND
No standard guideline has been established for the treatment of plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemoth... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, METHOTREXATE, MYCOPHENOLIC ACID, SEMUSTINE, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY | 33607779 | 18,990,270 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fungal infection'. | Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.
BACKGROUND
No standard guideline has been established for the treatment of plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemoth... | BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, METHOTREXATE, MYCOPHENOLIC ACID, SEMUSTINE, THYMOCYTE IMMUNE GLOBULIN NOS | DrugsGivenReaction | CC BY | 33607779 | 18,990,270 | 2021-02-19 |
What was the dosage of drug 'BUSULFAN'? | Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.
BACKGROUND
No standard guideline has been established for the treatment of plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemoth... | 51.6MG Q6H ?8, ?7, ?6 | DrugDosageText | CC BY | 33607779 | 18,990,270 | 2021-02-19 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.
BACKGROUND
No standard guideline has been established for the treatment of plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemoth... | 3G ?5, ?4 | DrugDosageText | CC BY | 33607779 | 18,990,270 | 2021-02-19 |
What was the dosage of drug 'CYTARABINE'? | Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.
BACKGROUND
No standard guideline has been established for the treatment of plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemoth... | 3.5G ?10, ?9 | DrugDosageText | CC BY | 33607779 | 18,990,270 | 2021-02-19 |
What was the dosage of drug 'METHOTREXATE'? | Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.
BACKGROUND
No standard guideline has been established for the treatment of plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemoth... | SHORT?TERM METHOTREXATE | DrugDosageText | CC BY | 33607779 | 18,990,270 | 2021-02-19 |
What was the dosage of drug 'SEMUSTINE'? | Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.
BACKGROUND
No standard guideline has been established for the treatment of plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemoth... | MECCNU 450MG ?3 | DrugDosageText | CC BY | 33607779 | 18,990,270 | 2021-02-19 |
What was the dosage of drug 'THYMOCYTE IMMUNE GLOBULIN NOS'? | Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.
BACKGROUND
No standard guideline has been established for the treatment of plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemoth... | 2.5MG/KG ?5, ?4, ?3, ?2 | DrugDosageText | CC BY | 33607779 | 18,990,270 | 2021-02-19 |
What was the outcome of reaction 'Cystitis haemorrhagic'? | Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.
BACKGROUND
No standard guideline has been established for the treatment of plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemoth... | Recovered | ReactionOutcome | CC BY | 33607779 | 18,990,270 | 2021-02-19 |
What was the outcome of reaction 'Fungal infection'? | Allogeneic hematopoietic stem cell transplantation in a patient with HIV-negative recurrent plasmablastic lymphoma: A case report.
BACKGROUND
No standard guideline has been established for the treatment of plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemoth... | Recovered | ReactionOutcome | CC BY | 33607779 | 18,990,270 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Orthostatic hypotension'. | D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report.
BACKGROUND
Cisplatin is one of the key drugs that is frequently used for treating various types of malignancies. Although renal and digestive toxicities are well-known cisplatin-related toxicities, attention should also be paid t... | CALCIUM CARBONATE, CHOLECALCIFEROL, CISPLATIN, FEBUXOSTAT, GIMERACIL\OTERACIL\TEGAFUR, LEVOTHYROXINE SODIUM, MAGNESIUM CARBONATE | DrugsGivenReaction | CC BY | 33607810 | 18,948,862 | 2021-02-19 |
What is the weight of the patient? | D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report.
BACKGROUND
Cisplatin is one of the key drugs that is frequently used for treating various types of malignancies. Although renal and digestive toxicities are well-known cisplatin-related toxicities, attention should also be paid t... | 69.4 kg. | Weight | CC BY | 33607810 | 18,948,862 | 2021-02-19 |
What was the administration route of drug 'CISPLATIN'? | D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report.
BACKGROUND
Cisplatin is one of the key drugs that is frequently used for treating various types of malignancies. Although renal and digestive toxicities are well-known cisplatin-related toxicities, attention should also be paid t... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33607810 | 19,099,234 | 2021-02-19 |
What was the administration route of drug 'GIMERACIL\OTERACIL\TEGAFUR'? | D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report.
BACKGROUND
Cisplatin is one of the key drugs that is frequently used for treating various types of malignancies. Although renal and digestive toxicities are well-known cisplatin-related toxicities, attention should also be paid t... | Oral | DrugAdministrationRoute | CC BY | 33607810 | 19,099,234 | 2021-02-19 |
What was the dosage of drug 'CALCIUM CARBONATE'? | D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report.
BACKGROUND
Cisplatin is one of the key drugs that is frequently used for treating various types of malignancies. Although renal and digestive toxicities are well-known cisplatin-related toxicities, attention should also be paid t... | PRECIPITATED | DrugDosageText | CC BY | 33607810 | 18,948,862 | 2021-02-19 |
What was the outcome of reaction 'Orthostatic hypotension'? | D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report.
BACKGROUND
Cisplatin is one of the key drugs that is frequently used for treating various types of malignancies. Although renal and digestive toxicities are well-known cisplatin-related toxicities, attention should also be paid t... | Recovered | ReactionOutcome | CC BY | 33607810 | 18,948,862 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Detachment of retinal pigment epithelium'. | Optical coherence tomography angiography for the diagnosis of granulomatosis with polyangiitis with serous retinal detachment: A case report.
BACKGROUND
Granulomatosis with polyangiitis (GPA) is a rare systemic autoimmune disease of unknown etiology. GPA affects multiple ocular tissues, most commonly the orbit, conjunc... | MIZORIBINE, PREDNISOLONE | DrugsGivenReaction | CC BY | 33607834 | 19,040,654 | 2021-02-19 |
What was the administration route of drug 'PREDNISOLONE SODIUM PHOSPHATE'? | Optical coherence tomography angiography for the diagnosis of granulomatosis with polyangiitis with serous retinal detachment: A case report.
BACKGROUND
Granulomatosis with polyangiitis (GPA) is a rare systemic autoimmune disease of unknown etiology. GPA affects multiple ocular tissues, most commonly the orbit, conjunc... | Oral | DrugAdministrationRoute | CC BY | 33607834 | 19,043,627 | 2021-02-19 |
What was the dosage of drug 'MIZORIBINE'? | Optical coherence tomography angiography for the diagnosis of granulomatosis with polyangiitis with serous retinal detachment: A case report.
BACKGROUND
Granulomatosis with polyangiitis (GPA) is a rare systemic autoimmune disease of unknown etiology. GPA affects multiple ocular tissues, most commonly the orbit, conjunc... | 100 MILLIGRAM | DrugDosageText | CC BY | 33607834 | 20,466,810 | 2021-02-19 |
What was the dosage of drug 'UNSPECIFIED INGREDIENT'? | Optical coherence tomography angiography for the diagnosis of granulomatosis with polyangiitis with serous retinal detachment: A case report.
BACKGROUND
Granulomatosis with polyangiitis (GPA) is a rare systemic autoimmune disease of unknown etiology. GPA affects multiple ocular tissues, most commonly the orbit, conjunc... | 1000 MILLIGRAM | DrugDosageText | CC BY | 33607834 | 20,466,810 | 2021-02-19 |
What was the outcome of reaction 'Chorioretinopathy'? | Optical coherence tomography angiography for the diagnosis of granulomatosis with polyangiitis with serous retinal detachment: A case report.
BACKGROUND
Granulomatosis with polyangiitis (GPA) is a rare systemic autoimmune disease of unknown etiology. GPA affects multiple ocular tissues, most commonly the orbit, conjunc... | Recovering | ReactionOutcome | CC BY | 33607834 | 19,040,654 | 2021-02-19 |
What was the outcome of reaction 'Detachment of retinal pigment epithelium'? | Optical coherence tomography angiography for the diagnosis of granulomatosis with polyangiitis with serous retinal detachment: A case report.
BACKGROUND
Granulomatosis with polyangiitis (GPA) is a rare systemic autoimmune disease of unknown etiology. GPA affects multiple ocular tissues, most commonly the orbit, conjunc... | Recovering | ReactionOutcome | CC BY | 33607834 | 19,040,654 | 2021-02-19 |
What was the outcome of reaction 'Serous retinal detachment'? | Optical coherence tomography angiography for the diagnosis of granulomatosis with polyangiitis with serous retinal detachment: A case report.
BACKGROUND
Granulomatosis with polyangiitis (GPA) is a rare systemic autoimmune disease of unknown etiology. GPA affects multiple ocular tissues, most commonly the orbit, conjunc... | Recovering | ReactionOutcome | CC BY | 33607834 | 19,040,654 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Choroidal neovascularisation'. | Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
BACKGROUND
Half-dose or reduced-fluence photodynamic therapy (PDT) with verteporfin has been well acknowledged to be the most effective and permanent treatment with very low rates of com... | VERTEPORFIN | DrugsGivenReaction | CC BY | 33607835 | 18,984,537 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Detachment of retinal pigment epithelium'. | Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
BACKGROUND
Half-dose or reduced-fluence photodynamic therapy (PDT) with verteporfin has been well acknowledged to be the most effective and permanent treatment with very low rates of com... | VERTEPORFIN | DrugsGivenReaction | CC BY | 33607835 | 18,984,537 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
BACKGROUND
Half-dose or reduced-fluence photodynamic therapy (PDT) with verteporfin has been well acknowledged to be the most effective and permanent treatment with very low rates of com... | VERTEPORFIN | DrugsGivenReaction | CC BY | 33607835 | 18,984,537 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Retinal haemorrhage'. | Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
BACKGROUND
Half-dose or reduced-fluence photodynamic therapy (PDT) with verteporfin has been well acknowledged to be the most effective and permanent treatment with very low rates of com... | VERTEPORFIN | DrugsGivenReaction | CC BY | 33607835 | 18,984,537 | 2021-02-19 |
What was the administration route of drug 'VERTEPORFIN'? | Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
BACKGROUND
Half-dose or reduced-fluence photodynamic therapy (PDT) with verteporfin has been well acknowledged to be the most effective and permanent treatment with very low rates of com... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33607835 | 18,984,537 | 2021-02-19 |
What was the dosage of drug 'VERTEPORFIN'? | Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
BACKGROUND
Half-dose or reduced-fluence photodynamic therapy (PDT) with verteporfin has been well acknowledged to be the most effective and permanent treatment with very low rates of com... | ALONG WITH HALF?DOSE PDT | DrugDosageText | CC BY | 33607835 | 18,984,537 | 2021-02-19 |
What was the outcome of reaction 'Choroidal neovascularisation'? | Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
BACKGROUND
Half-dose or reduced-fluence photodynamic therapy (PDT) with verteporfin has been well acknowledged to be the most effective and permanent treatment with very low rates of com... | Recovered | ReactionOutcome | CC BY | 33607835 | 18,984,537 | 2021-02-19 |
What was the outcome of reaction 'Product use in unapproved indication'? | Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
BACKGROUND
Half-dose or reduced-fluence photodynamic therapy (PDT) with verteporfin has been well acknowledged to be the most effective and permanent treatment with very low rates of com... | Recovered | ReactionOutcome | CC BY | 33607835 | 18,984,537 | 2021-02-19 |
What was the outcome of reaction 'Retinal haemorrhage'? | Choroidal neovascularization secondary to half-dose photodynamic therapy for chronic central serous chorioretinopathy: A case report.
BACKGROUND
Half-dose or reduced-fluence photodynamic therapy (PDT) with verteporfin has been well acknowledged to be the most effective and permanent treatment with very low rates of com... | Recovered | ReactionOutcome | CC BY | 33607835 | 18,984,537 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterocolitis'. | Treatment with Ramucirumab-paclitaxel in a metastatic gastric cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Ramucirumab, a human Ig 1 monoclonal antibody against vascular endothelial growth factor receptor-2, in combination with paclitaxel is a second-line chemotherapy for patients with metastatic g... | IRINOTECAN | DrugsGivenReaction | CC BY | 33607838 | 18,995,994 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Treatment with Ramucirumab-paclitaxel in a metastatic gastric cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Ramucirumab, a human Ig 1 monoclonal antibody against vascular endothelial growth factor receptor-2, in combination with paclitaxel is a second-line chemotherapy for patients with metastatic g... | IRINOTECAN | DrugsGivenReaction | CC BY | 33607838 | 18,995,994 | 2021-02-19 |
What is the weight of the patient? | Treatment with Ramucirumab-paclitaxel in a metastatic gastric cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Ramucirumab, a human Ig 1 monoclonal antibody against vascular endothelial growth factor receptor-2, in combination with paclitaxel is a second-line chemotherapy for patients with metastatic g... | 57 kg. | Weight | CC BY | 33607838 | 18,995,994 | 2021-02-19 |
What was the dosage of drug 'IRINOTECAN'? | Treatment with Ramucirumab-paclitaxel in a metastatic gastric cancer patient undergoing hemodialysis: A case report.
BACKGROUND
Ramucirumab, a human Ig 1 monoclonal antibody against vascular endothelial growth factor receptor-2, in combination with paclitaxel is a second-line chemotherapy for patients with metastatic g... | CYCLE 1 | DrugDosageText | CC BY | 33607838 | 18,995,994 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection.
BACKGROUND
The management of unresectable locally advanced colon cancer (LACC) remains controversial, as resection is not feasible. T... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY | 33607964 | 18,966,748 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytokine release syndrome'. | Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
BACKGROUND
Very little is known about the risk that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection poses to cancer patients, many of whom are immune compromised cau... | BORTEZOMIB, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, INVESTIGATIONAL PRODUCT, MELPHALAN, MEZAGITAMAB | DrugsGivenReaction | CC BY | 33608053 | 19,598,038 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
BACKGROUND
Very little is known about the risk that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection poses to cancer patients, many of whom are immune compromised cau... | BORTEZOMIB, CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, INVESTIGATIONAL PRODUCT, MELPHALAN, MEZAGITAMAB | DrugsGivenReaction | CC BY | 33608053 | 19,598,038 | 2021-02-19 |
What was the administration route of drug 'INVESTIGATIONAL PRODUCT'? | Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
BACKGROUND
Very little is known about the risk that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection poses to cancer patients, many of whom are immune compromised cau... | Other | DrugAdministrationRoute | CC BY | 33608053 | 19,598,038 | 2021-02-19 |
What was the outcome of reaction 'COVID-19'? | Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
BACKGROUND
Very little is known about the risk that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection poses to cancer patients, many of whom are immune compromised cau... | Recovered | ReactionOutcome | CC BY | 33608053 | 19,573,417 | 2021-02-19 |
What was the outcome of reaction 'Cytokine release syndrome'? | Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
BACKGROUND
Very little is known about the risk that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection poses to cancer patients, many of whom are immune compromised cau... | Recovered | ReactionOutcome | CC BY | 33608053 | 19,598,038 | 2021-02-19 |
What was the outcome of reaction 'Lymphopenia'? | Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
BACKGROUND
Very little is known about the risk that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection poses to cancer patients, many of whom are immune compromised cau... | Not recovered | ReactionOutcome | CC BY | 33608053 | 19,573,417 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | SRP-positive necrotising myopathy: takes more than just the muscles.
Necrotising myopathy is an autoimmune disease that commonly affects muscles. Here we examine a case of a middle-aged women presenting with a chief report of shortness of breath, who subsequently developed muscle weakness. Her clinical course was compl... | MYCOPHENOLATE MOFETIL, PREDNISONE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC | 33608334 | 19,753,479 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | SRP-positive necrotising myopathy: takes more than just the muscles.
Necrotising myopathy is an autoimmune disease that commonly affects muscles. Here we examine a case of a middle-aged women presenting with a chief report of shortness of breath, who subsequently developed muscle weakness. Her clinical course was compl... | MYCOPHENOLATE MOFETIL, PREDNISONE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC | 33608334 | 19,753,479 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | SRP-positive necrotising myopathy: takes more than just the muscles.
Necrotising myopathy is an autoimmune disease that commonly affects muscles. Here we examine a case of a middle-aged women presenting with a chief report of shortness of breath, who subsequently developed muscle weakness. Her clinical course was compl... | MYCOPHENOLATE MOFETIL, PREDNISONE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC | 33608334 | 19,753,479 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysphagia'. | SRP-positive necrotising myopathy: takes more than just the muscles.
Necrotising myopathy is an autoimmune disease that commonly affects muscles. Here we examine a case of a middle-aged women presenting with a chief report of shortness of breath, who subsequently developed muscle weakness. Her clinical course was compl... | MYCOPHENOLATE MOFETIL, PREDNISONE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC | 33608334 | 19,753,479 | 2021-02-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | SRP-positive necrotising myopathy: takes more than just the muscles.
Necrotising myopathy is an autoimmune disease that commonly affects muscles. Here we examine a case of a middle-aged women presenting with a chief report of shortness of breath, who subsequently developed muscle weakness. Her clinical course was compl... | MYCOPHENOLATE MOFETIL, PREDNISONE, SIMVASTATIN | DrugsGivenReaction | CC BY-NC | 33608334 | 19,753,479 | 2021-02-19 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | SRP-positive necrotising myopathy: takes more than just the muscles.
Necrotising myopathy is an autoimmune disease that commonly affects muscles. Here we examine a case of a middle-aged women presenting with a chief report of shortness of breath, who subsequently developed muscle weakness. Her clinical course was compl... | UNKNOWN | DrugDosageText | CC BY-NC | 33608334 | 19,753,479 | 2021-02-19 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.